Marshall Wace’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.8K | Buy |
+53,678
| New | +$77.8K | ﹤0.01% | 2420 |
|
|
2025
Q1 | – | Sell |
-43,969
| Closed | -$134K | – | 2902 |
|
|
2024
Q4 | $134K | Sell |
43,969
-121,191
| -73% | -$368K | ﹤0.01% | 2245 |
|
|
2024
Q3 | $822K | Sell |
165,160
-142,327
| -46% | -$709K | ﹤0.01% | 1597 |
|
|
2024
Q2 | $1.8M | Buy |
307,487
+116,316
| +61% | +$680K | ﹤0.01% | 1296 |
|
|
2024
Q1 | $1.52M | Buy |
191,171
+80,620
| +73% | +$640K | ﹤0.01% | 1294 |
|
|
2023
Q4 | $645K | Buy |
+110,551
| New | +$645K | ﹤0.01% | 1350 |
|